|
26 May 2011 |
Mymetics Realizes Successful Phase I Study With Its Innovative HIV Vaccine MYM-V101
|
|
25 May 2011 |
The ACTG Immunizes First Subject in Clinical Trial of Profectus BioSciences’ Therapeutic HIV DNA Vaccine
|
|
25 May 2011 |
Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
|
|
24 May 2011 |
ImmunoCellular Therapeutics to Present New Data from Phase I Study of ICT-107 in Glioblastoma Multiforme at ASCO 2011
|
|
24 May 2011 |
Paladin Labs Files New Drug Submission for Oralair(TM)
|
|
20 May 2011 |
Celiac Disease Vaccine Shows Promising Results in Phase I Trial
|
|
19 May 2011 |
Advantagene Announces SPA Agreement With FDA to Launch Phase 3 Trial for Novel Vaccine Aimed at Preventing Prostate Cancer Recurrence
|
|
17 May 2011 |
DBV Demonstrates Ability of VIASKIN to Administer Allergen via Intact Skin by Targeting Dendritic Cells for Safe Treatment of Allergic Disease
|
|
10 May 2011 |
FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection
|
|
09 May 2011 |
Pfizer’s Prevnar 13 Meets All Study Endpoints In Two Pivotal Phase 3 Trials In Adults Aged 50 And Older Presented Today
|
|
09 May 2011 |
Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study
|
|
09 May 2011 |
Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
|
|
09 May 2011 |
ImmusanT Reports Positive Results from Nexvax2 Phase 1 Study in Celiac Disease
|
|
06 May 2011 |
KAEL-GemVax: TeloVac Becomes World’s Largest Ever Pancreatic Cancer Vaccine Trial
|
|
05 May 2011 |
ImmunoCellular Therapeutics Announces Updated Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma
|
|
03 May 2011 |
Isconova strengthens product and patent portfolio
|
|
02 May 2011 |
Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
|
|
27 Apr 2011 |
Vical Announces Encouraging H1N1 Pandemic Influenza Vaccine Phase 1 Results
|
|
25 Apr 2011 |
Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
|
|
21 Apr 2011 |
Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases
|
|
20 Apr 2011 |
NanoBio Announces Development of Nasal Vaccine for the Prevention of Urinary Tract Infections in Collaboration with the University of Michigan
|
|
19 Apr 2011 |
Adamis Completes Acquisition of a Technology for a Potential Universal Cancer Vaccine
|
|
18 Apr 2011 |
Biotech Synergy Acquires Multi-Epitope NSCLC Cancer Vaccine Phase 2 Positive Assets and Related Patents
|
|
18 Apr 2011 |
Advaxis Lead Drug ADXS11-001 Well-Tolerated in 72 Patients, to Date
|
|
18 Apr 2011 |
Aduro BioTech Licenses GVAX Pancreas from BioSante Pharmaceuticals to Develop a Therapeutic Vaccine in Conjunction with CRS-207 for Pancreatic Cancer
|
